6-1-1-4 ⓔ文献
Brooks PM, Day RO: Nonsteroidal antiinflammatory drugs–differences and similarities. N Engl J Med, 1991; 324: 1716–1725.
Dubois RN, Abramson SB, et al: Cyclooxygenase in biology and disease. FASEB J, 1998; 12: 1063–1073.
高崎芳成：非ステロイド系消炎鎮痛薬 (NSAIDs)．関節リウマチの診療マニュアル (改訂版)，診断のマニュアルとEBMに基づく治療ガイドライン 改訂版 (厚生労働省研究班編)，日本リウマチ財団，2004; 71–77.
Burke A, Smyth E, et al: Analgesic–antipyretic agents; pharmacotherapy of gout. Goodman and Gilman’s the Pharmacologic Basis of Therapeutics, 11 th ed (Brunton LL, Lazo JS, et al eds), McGraw-Hill, 2006; 671–715.
日本消化器病学会：消化性潰瘍ガイドライン2015改訂第2版，南江堂，2015．
薬剤性腎障害の診療ガイドライン作成委員会：薬剤性腎障害診療ガイドライン2016．日本腎臓学会誌，2016; 58: 477–555．
Sriuttha P, Sriuttha B, et al: Hepatotoxicity of nonsteroidal anti–inflammatory drugs: a systematic review of randomized controlled Trial. Int J Hepatol, 2018; 2018: 5253623.
TreLLe S, Stephan R, et al: Cardiovascular safety of non–steroidal anti–inflammatory drugs: network meta–analysis. BMJ, 2011; 342: c7086．
Coxib and traditional NSAID Trialists’(CNT) Collaboration, Bhala N, et al: Vascular and upper gastrointestinal effects of non–steroidal anti–inflammatory drugs: meta–analyses of individual participant data from randomised trials. Lancet, 2013; 382: 769–779.
Kepa L, Oczko–Grzesik B, et al: Drug–induced aseptic meningitis insuspected central nervous system infections. J Clin Neurosci, 2005; 12: 562–564.